Tag Archive for: biotech

Destiny Pharma: Major US hospital-based clinical trial highlights benefit of nasal decolonization to reduce ICU infections caused by Staphylococcus aureus

/in

Major US hospital-based clinical trial highlights benefit of nasal decolonization to reduce ICU infections caused by Staphylococcus aureus Strong support for potential of XF-73 nasal product as alternative to mupirocin Brighton, United Kingdom – 18 October 2021 – Destiny Pharma (AIM: DEST), a clinical stage biotechnology company focused on the development of novel medicines to prevent life […]

Read more

6th Annual LSX Investival Showcase

/in

8-15 NOV 2021 | Hybrid

Read more

LSX Food Biotech Congress 2021

/in

8-12 NOV 2021 | Hybrid

Read more

Investor Q&A Series: Roel Bulthuis, INKEF Capital

/in

In our first Investor Q&A article, Roel Bulthuis, Managing Partner of INKEF Capital shares his thoughts on the investment landscape in Europe.

Read more

Concussion and Sports-Related Brain Injury: Prevention Vs Cure?

/in

One Nucleus’ BioWednesday Webinar discussed what R&D is underway to treat the effects of concussions, how new technologies are enabling better diagnoses…

Read more
© Optimum Strategic Communications.